Trademark: 79230146
Status Date
Tuesday, January 15, 2019
Registration Number
5652089
Registration Date
Tuesday, January 15, 2019
Filing Date
Thursday, February 1, 2018
Published for Opposition
Tuesday, October 30, 2018
5 Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS
Color is not claimed as a feature of the mark.
Jan 15, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Nov 5, 2021
New Representative At Ib Received
Feb 12, 2021
New Representative At Ib Received
May 25, 2019
Final Decision Transaction Processed By Ib
May 7, 2019
Final Disposition Notice Sent To Ib
May 6, 2019
Final Disposition Processed
Apr 15, 2019
Final Disposition Notice Created, To Be Sent To Ib
Jan 15, 2019
Registered-Principal Register
Oct 30, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 30, 2018
Published For Opposition
Oct 26, 2018
Notification Processed By Ib
Oct 10, 2018
Notification Of Possible Opposition Sent To Ib
Oct 10, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 10, 2018
Notification Of Notice Of Publication E-Mailed
Sep 17, 2018
Assigned To Lie
Sep 5, 2018
Approved For Pub - Principal Register
Aug 30, 2018
Examiner's Amendment Entered
Aug 30, 2018
Notification Of Examiners Amendment E-Mailed
Aug 30, 2018
Examiners Amendment E-Mailed
Aug 30, 2018
Examiners Amendment -Written
Aug 22, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 22, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 22, 2018
Teas Change Of Correspondence Received
Aug 22, 2018
Teas/Email Correspondence Entered
Aug 22, 2018
Correspondence Received In Law Office
Aug 22, 2018
Teas Response To Office Action Received
Jun 8, 2018
Refusal Processed By Ib
May 21, 2018
Non-Final Action Mailed - Refusal Sent To Ib
May 21, 2018
Refusal Processed By Mpu
May 16, 2018
Non-Final Action (Ib Refusal) Prepared For Review
May 15, 2018
Non-Final Action Written
May 15, 2018
Assigned To Examiner
Apr 17, 2018
Application Filing Receipt Mailed
Apr 13, 2018
New Application Office Supplied Data Entered
Apr 12, 2018
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
